Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis.
作者： Sufei Wang , Pei Ma , Guanzhou Ma , Zhilei Lv , Feng Wu
DOI: 10.1016/J.EJCA.2019.10.005
关键词:
摘要: … mutations and ALK positivity have been targeted because of their high incidence. TKIs … In conclusion, this is the largest retrospective study to investigate whether EGFR mutation and …
sci-hub.se 参考文章(37)
Imran Ali, Kishwar Saleem, Diana Wesselinova, Ashanul Haque, Synthesis, DNA binding, hemolytic, and anti-cancer assays of curcumin I-based ligands and their ruthenium(III) complexes Medicinal Chemistry Research. ,vol. 22, pp. 1386- 1398 ,(2013) , 10.1007/S00044-012-0133-8
Cong Xue, Zhihuang Hu, Wei Jiang, Yuanyuan Zhao, Fei Xu, Yan Huang, Hongyun Zhao, Jingxun Wu, Yang Zhang, Liping Zhao, Jing Zhang, Likun Chen, Li Zhang, National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China Lung Cancer. ,vol. 77, pp. 371- 375 ,(2012) , 10.1016/J.LUNGCAN.2012.04.014
Takayuki Fukui, Yasushi Yatabe, Yoshihisa Kobayashi, Kenji Tomizawa, Simon Ito, Shunzo Hatooka, Keitaro Matsuo, Tetsuya Mitsudomi, Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene Lung Cancer. ,vol. 77, pp. 319- 325 ,(2012) , 10.1016/J.LUNGCAN.2012.03.013
Lecia V. Sequist, Daphne W. Bell, Thomas J. Lynch, Daniel A. Haber, Molecular Predictors of Response to Epidermal Growth Factor Receptor Antagonists in Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 25, pp. 587- 595 ,(2007) , 10.1200/JCO.2006.07.3585
Motoki Yano, Hidefumi Sasaki, Yoshihiro Kobayashi, Haruhiro Yukiue, Hiroshi Haneda, Eriko Suzuki, Katsuhiko Endo, Osamu Kawano, Masaki Hara, Yoshitaka Fujii, Epidermal Growth Factor Receptor Gene Mutation and Computed Tomographic Findings in Peripheral Pulmonary Adenocarcinoma Journal of Thoracic Oncology. ,vol. 1, pp. 413- 416 ,(2006) , 10.1016/S1556-0864(15)31604-X
Shaodong Hong, Wenfeng Fang, Zhihuang Hu, Ting Zhou, Yue Yan, Tao Qin, Yanna Tang, Yuxiang Ma, Yuanyuan Zhao, Cong Xue, Yan Huang, Hongyun Zhao, Li Zhang, A Large-scale Cross-sectional Study of ALK Rearrangements and EGFR Mutations in Non-small-cell Lung Cancer in Chinese Han Population Scientific Reports. ,vol. 4, pp. 7268- 7268 ,(2015) , 10.1038/SREP07268
Bo Jin, Yu Dong, Hui-min Wang, Jin-su Huang, Bao-hui Han, Correlation between serum CEA levels and EGFR mutations in Chinese nonsmokers with lung adenocarcinoma. Acta Pharmacologica Sinica. ,vol. 35, pp. 373- 380 ,(2014) , 10.1038/APS.2013.164
I. Ali, Nano anti-cancer drugs: pros and cons and future perspectives. Current Cancer Drug Targets. ,vol. 11, pp. 131- 134 ,(2011) , 10.2174/156800911794328457
Daisy Wing-Sze Wong, Elaine Lai-Han Leung, Kimpton Kam-Ting So, Issan Yee-San Tam, Alan Dart-Loon Sihoe, Lik-Cheung Cheng, Kwok-Keung Ho, Joseph Siu-Kie Au, Lap-Ping Chung, Maria Pik Wong, , The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer. ,vol. 115, pp. 1723- 1733 ,(2009) , 10.1002/CNCR.24181
Kishwar Saleem, Waseem A Wani, Ashanul Haque, Mohamad Nadeem Lone, Ming-Fa Hsieh, Mohamad Aman Jairajpuri, Imran Ali, Synthesis, DNA binding, hemolysis assays and anticancer studies of copper(II), nickel(II) and iron(III) complexes of a pyrazoline-based ligand. Future Medicinal Chemistry. ,vol. 5, pp. 135- 146 ,(2013) , 10.4155/FMC.12.201